The Loft: Where Gen Z Goes to Build Relationships and Discover Spiritual Truths

It is an alarming but indisputable fact that the vast majority of Generation Z, specifically those between ages 18 and 25, are not attending and/or not interested in the faith or beliefs of the American Protestant Church today. Studies show that the Western Christian church is losing touch with an entire generation and that reality is the driving force behind this research project. We know from research conducted for this Doctoral Project, as well as from multiple academic and sociological studies that members of Generation Z are often interested in spirituality but are either ignorant or highly skeptical of organized religion. Along with the culturally preconceived idea that the Christian Church is narrow-minded, outdated, and intolerant, this poses a significant problem for faith leaders attempting to reach Generation Z. While formulating this Doctoral Project, I asked: “How can faith leaders connect with this generation in a relevant, viable, and appealing way, which could result in healthy relationships and, ultimately, point young adults to Jesus? Could the Church model Jesus in such a way that young adults become curious about faith and relationship in Jesus?” “If so, how and where?” I will present the idea, proven by data and testing, that the creation of a third space model (named “The Loft”) in which entertaining, interactive, and enlightening activities that appeal to Generation Z are regularly hosted in a neutral, non-threatening environment with a focus on building relationships could be a place where the Holy Spirit could use these authentic relationships to change lives and lead participants to Jesus ultimately

Design of mesoporous sol-gel coatings for anti-fingerprint applications on glass

peer reviewedNowadays, the use of mesoporous sol-gel films as smart coatings is growing. Their porosity is used to embed active species in applications such as drug delivery, catalysis, sensors, active corrosion protection, ... The film mesoporosity is produced by evaporation induced self-assembly (EISA) process. This process is based on the addition of a templating agent in sol-gel formulation. The thermal removal of surfactant agent allows to control the coating mesostructure. In this work, the mesostructure of the sol-gel layer is designed to be used as reservoir for active biomolecules. In order to assure a good incorporation and storage of biomolecules, the size of mesopores and their configuration were tuned as a function of application and synthesis parameters. The effects of the sol-gel composition and deposition process on the sol-gel mesostructure were evaluated. Scanning electron microscopy (SEM) and water adsorption/desorption isotherms recorded with a quartz crystal microbalance (QCM) were used to characterize the morphologies of the sol-gel film. Rheological measurements were carried out to check the stability of the sol-gel solution. The anti-fingerprint performance due to the combination of mesoporous film and enzymatic solutions were assessed by using an artificial sebum

Differences in the faecal microbiome in Schistosoma haematobium infected children vs. uninfected children

BACKGROUND: Several infectious diseases and therapeutic interventions cause gut microbe dysbiosis and associated pathology. We characterised the gut microbiome of children exposed to the helminth Schistosoma haematobium pre- and post-treatment with the drug praziquantel (PZQ), with the aim to compare the gut microbiome structure (abundance and diversity) in schistosome infected vs. uninfected children. METHODS: Stool DNA from 139 children aged six months to 13 years old; with S. haematobium infection prevalence of 27.34% was extracted at baseline. 12 weeks following antihelminthic treatment with praziqunatel, stool DNA was collected from 62 of the 139 children. The 16S rRNA genes were sequenced from the baseline and post-treatment samples and the sequence data, clustered into operational taxonomic units (OTUs). The OTU data were analysed using multivariate analyses and paired T-test. RESULTS: Pre-treatment, the most abundant phyla were Bacteroidetes, followed by Firmicutes and Proteobacteria respectively. The relative abundance of taxa among bacterial classes showed limited variation by age group or sex and the bacterial communities had similar overall compositions. Although there were no overall differences in the microbiome structure across the whole age range, the abundance of 21 OTUs varied significantly with age (FDR<0.05). Some OTUs including Veillonella, Streptococcus, Bacteroides and Helicobacter were more abundant in children ≤ 1 year old compared to older children. Furthermore, the gut microbiome differed in schistosome infected vs. uninfected children with 27 OTU occurring in infected but not uninfected children, for 5 of these all Prevotella, the difference was statistically significant (p <0.05) with FDR <0.05. PZQ treatment did not alter the microbiome structure in infected or uninfected children from that observed at baseline. CONCLUSIONS: There are significant differences in the gut microbiome structure of infected vs. uninfected children and the differences were refractory to PZQ treatment

Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease

Background: Experimental and clinical data suggest that reducing inflammation without affecting lipid levels may reduce the risk of cardiovascular disease. Yet, the inflammatory hypothesis of atherothrombosis has remained unproved. Methods: We conducted a randomized, double-blind trial of canakinumab, a therapeutic monoclonal antibody targeting interleukin-1β, involving 10,061 patients with previous myocardial infarction and a high-sensitivity C-reactive protein level of 2 mg or more per liter. The trial compared three doses of canakinumab (50 mg, 150 mg, and 300 mg, administered subcutaneously every 3 months) with placebo. The primary efficacy end point was nonfatal myocardial infarction, nonfatal stroke, or cardiovascular death. RESULTS: At 48 months, the median reduction from baseline in the high-sensitivity C-reactive protein level was 26 percentage points greater in the group that received the 50-mg dose of canakinumab, 37 percentage points greater in the 150-mg group, and 41 percentage points greater in the 300-mg group than in the placebo group. Canakinumab did not reduce lipid levels from baseline. At a median follow-up of 3.7 years, the incidence rate for the primary end point was 4.50 events per 100 person-years in the placebo group, 4.11 events per 100 person-years in the 50-mg group, 3.86 events per 100 person-years in the 150-mg group, and 3.90 events per 100 person-years in the 300-mg group. The hazard ratios as compared with placebo were as follows: in the 50-mg group, 0.93 (95% confidence interval [CI], 0.80 to 1.07; P = 0.30); in the 150-mg group, 0.85 (95% CI, 0.74 to 0.98; P = 0.021); and in the 300-mg group, 0.86 (95% CI, 0.75 to 0.99; P = 0.031). The 150-mg dose, but not the other doses, met the prespecified multiplicity-adjusted threshold for statistical significance for the primary end point and the secondary end point that additionally included hospitalization for unstable angina that led to urgent revascularization (hazard ratio vs. placebo, 0.83; 95% CI, 0.73 to 0.95; P = 0.005). Canakinumab was associated with a higher incidence of fatal infection than was placebo. There was no significant difference in all-cause mortality (hazard ratio for all canakinumab doses vs. placebo, 0.94; 95% CI, 0.83 to 1.06; P = 0.31). Conclusions: Antiinflammatory therapy targeting the interleukin-1β innate immunity pathway with canakinumab at a dose of 150 mg every 3 months led to a significantly lower rate of recurrent cardiovascular events than placebo, independent of lipid-level lowering. (Funded by Novartis; CANTOS ClinicalTrials.gov number, NCT01327846.

A Defence of simplification

This paper argues that simplified or graded readers are an essential part of a language learning program if learners of all proficiency levels are to have the opportunity to do incidental language learning through reading, and to develop fluency in reading. Unsimplified texts do not allow for this kind of learning at beginning and intermediate levels because they contain too great a density of unknown words and too many different unknown words. Evidence is provided to support this from a corpus study of versions of Dracula. Many criticisms of simplified texts apply only to poorly simplified texts and to the poor use of such texts in curriculum planning.13 page(s

Polymyosite associee a l'immuno-deficience VIH :CAS clinique et revue de la litterature

SCOPUS: re.jinfo:eu-repo/semantics/publishe